Newton, Mass., USA - May 16, 2014, Newton, Mass., USA - Alcresta, a medical nutrition company, announced the appointment of John H. Tucker as chief executive officer.
Article continues below
Mr. Tucker, former senior vice president and chief commercial officer of Incline Therapeutics, brings to Alcresta more than 20 years of commercial experience in the biotechnology and pharmaceutical industries and has successfully led numerous product launches.
Prior to Alcresta, Mr. Tucker served as senior vice president and chief commercial officer of
Incline Therapeutics, a hospital-focused specialty pharmaceutical company.
There, he developed and drove the overall commercial strategy in support of the company’s lead product, IONSYS, resulting in a purchase of Incline by The Medicines Company.
He joined Incline from AMAG Pharmaceuticals, where he was senior vice president, commercial operations, responsible for all sales and marketing activities for the company.
Previously, as president, U.S. operations at Basilea Pharmaceuticals, Mr. Tucker developed the strategy and organization for the planned launch of a hospital-focused product and led the company’s commercial development team.
Prior to Basilea, Mr. Tucker was executive vice president, sales and marketing at Indevus
Pharmaceuticals.
Earlier in his career, he held a variety of both hospital and retail-based sales and marketing positions with increasing levels of responsibility at Ortho-McNeil Pharmaceuticals, ALZA Corporation, VIVUS and UCB Pharma.
Mr. Tucker holds a B.A. from Plymouth State College and an MBA from New Hampshire College.
Co-founder and former CEO Alexey Margolin will be chairman of the company’s board of
directors.
Dr. Margolin is the co-founder and CEO of Alcresta. He also currently serves as co-founder, president and CEO of Allena Pharmaceuticals.
Prior to Alcresta and Allena, Dr. Margolin co-founded Alnara Pharmaceuticals in 2008, where he served as CEO until 2010 when the company was acquired by Eli Lilly and Company.
He also served as chief scientific officer and senior vice president of research & pre-clinical development of Altus Pharmaceuticals, Inc.
Dr. Margolin is an expert in the fields of drug development, protein stabilization, crystallization and biocatalysis.
He is the author of more than 60 publications and is an inventor on several patents in these areas.
In 2003, Dr. Margolin was elected fellow of the American Institute of Medicine and Biological Engineering. ■